Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Zealand Completes Funding, Seeks New ZP10 Partnership

April 2, 2003

By Cormac Sheridan

Irish Delegation Visiting NIH To Seek Licensing Opportunities

April 2, 2003

By Cormac Sheridan

BioXell Moves BXL-628 Into Phase II Clinical Trial For BPH

April 2, 2003

By Cormac Sheridan

Basilea Planning Phase III Trial Of Lead Drug For Hand Dermatitis

March 26, 2003

By Cormac Sheridan

Biovitrum Moves Diabetes Drug Into Controlled Phase II Study

March 26, 2003

By Cormac Sheridan

Biovitrum Moves Diabetes Drug Into Controlled Phase II Study

March 26, 2003

By Cormac Sheridan

Basilea Planning Phase III Trial Of Lead Drug For Hand Dermatitis

March 26, 2003

By Cormac Sheridan

OncoGenome Sciences Raises EUR14M For Cancer Diagnostics

March 19, 2003

By Cormac Sheridan

OncoGenome Sciences Raises EUR14M For Cancer Diagnostics

March 19, 2003

By Cormac Sheridan

Irish Foundation's Grants For IT, For Life Sciences Nears EUR200M

March 12, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...